Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Asherman Syndrome
NCT04308811Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2019
- Primary completion
- Feb 2020
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous platelet-rich plasma in Asherman syndrome (IUA), sponsored by Ain Shams University. Started Aug 2019; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Asherman syndrome (IUA)
Beyond the preview
Go deeper on NCT04308811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04308811.